37496 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 07
16:10 UTC
|
LPLA
LPL Financial
|
◎ Target | Benjamin Budish ★★★☆☆ #2230 | Overweight | $401.00→ $409.00+2.0% |
|
Oct 07
16:10 UTC
|
LNC
Lincoln National
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $45.00→ $48.00+6.7% |
|
Oct 07
16:10 UTC
|
JXN
Jackson Financial
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $149.00→ $150.00+0.7% |
|
Oct 07
16:10 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Benjamin Budish ★★★☆☆ #2230 | Overweight | $105.00→ $132.00+25.7% |
|
Oct 07
16:10 UTC
|
DVN
Devon Energy
|
◎ Target | Gabe Daoud not yet tracked | Buy | $65.00→ $61.00-6.2% |
|
Oct 07
16:10 UTC
|
DGX
Quest Diagnostics
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $250.00→ $260.00+4.0% |
|
Oct 07
16:10 UTC
|
COP
ConocoPhillips
|
◎ Target | Gabe Daoud not yet tracked | Hold | $130.00→ $136.00+4.6% |
|
Oct 07
16:10 UTC
|
CHRW
C.H. Robinson Worldwide
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Buy | $215.00→ $200.00-7.0% |
|
Oct 07
16:10 UTC
|
ARCB
ArcBest
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Buy | $165.00→ $160.00-3.0% |
|
Oct 07
16:10 UTC
|
AMGN
Amgen
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Hold | $362.00→ $380.00+5.0% |
|
Oct 07
16:10 UTC
|
AGIO
Agios Pharmaceuticals
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $39.00→ $37.00-5.1% |
|
Oct 07
15:10 UTC
|
WHR
Whirlpool
|
◎ Target | Mike Dahl not yet tracked | Underperform | $32.00→ $22.00-31.2% |
|
Oct 07
15:10 UTC
|
VIR
Vir Biotechnology
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $20.00→ $22.00+10.0% |
|
Oct 07
15:10 UTC
|
SITE
SiteOne Landscape Supply
|
◎ Target | Mike Dahl not yet tracked | Outperform | $135.00→ $124.00-8.1% |
|
Oct 07
15:10 UTC
|
RPM
RPM International
|
◎ Target | Arun Viswanathan ★★★☆☆ #2190 | Outperform | $128.00→ $120.00-6.2% |
|
Oct 07
15:10 UTC
|
QXO
QXO
|
◎ Target | Mike Dahl not yet tracked | Outperform | $27.00→ $18.00-33.3% |
|
Oct 07
15:10 UTC
|
NG
Novagold Resources
|
◎ Target | Carlos De Alba ★★★☆☆ #2201 | Overweight | $13.60→ $13.00-4.4% |
|
Oct 07
15:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | Srini Pajjuri ★★★☆☆ #1850 | Outperform | $360.00→ $425.00+18.1% |
|
Oct 07
15:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | Joseph Moore ★★★☆☆ #1899 | Equal Weight | $268.00→ $300.00+11.9% |
|
Oct 07
15:10 UTC
|
MRNA
Moderna
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Equal Weight | $89.00→ $95.00+6.7% |
|
Oct 07
15:10 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Overweight | $179.00→ $177.00-1.1% |
|
Oct 07
15:10 UTC
|
MP
MP Materials
|
◎ Target | Carlos De Alba ★★★☆☆ #2201 | Overweight | $73.00→ $66.00-9.6% |
|
Oct 07
15:10 UTC
|
MAS
Masco
|
◎ Target | Mike Dahl not yet tracked | Sec→ r Perform | $72.00→ $69.00-4.2% |
|
Oct 07
15:10 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Overweight | $1,419.00→ $1,430.00+0.8% |
|
Oct 07
15:10 UTC
|
IQV
IQVIA
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $275.00→ $300.00+9.1% |
|
Oct 07
15:10 UTC
|
ILMN
Illumina
|
◎ Target | Luke Sergott ★★★★☆ #948 | Underweight | $160.00→ $200.00+25.0% |
|
Oct 07
15:10 UTC
|
IBP
Installed Building Products
|
◎ Target | Mike Dahl not yet tracked | Sec→ r Perform | $228.00→ $208.00-8.8% |
|
Oct 07
15:10 UTC
|
GILD
Gilead Sciences
|
◎ Target | Matthew Harrison not yet tracked | Overweight | $165.00→ $163.00-1.2% |
|
Oct 07
15:10 UTC
|
GH
Guardant Health
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $200.00→ $220.00+10.0% |
|
Oct 07
15:10 UTC
|
FG
F&G Annuities & Life
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Equal Weight | $27.00→ $24.00-11.1% |
|
Oct 07
15:10 UTC
|
FERG
Ferguson
|
◎ Target | Mike Dahl not yet tracked | Outperform | $290.00→ $286.00-1.4% |
|
Oct 07
15:10 UTC
|
FCX
Freeport-McMoRan
|
◎ Target | Carlos De Alba ★★★☆☆ #2201 | Equal Weight | $70.00→ $75.00+7.1% |
|
Oct 07
15:10 UTC
|
FBIN
Fortune Brands Innovations
|
◎ Target | Mike Dahl not yet tracked | Outperform | $57.00→ $49.00-14.0% |
|
Oct 07
15:10 UTC
|
EQH
Equitable
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $52.00→ $61.00+17.3% |
|
Oct 07
15:10 UTC
|
ELV
Elevance Health
|
◎ Target | Andrew Mok not yet tracked | Overweight | $457.00→ $469.00+2.6% |
|
Oct 07
15:10 UTC
|
DHR
Danaher
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $230.00→ $255.00+10.9% |
|
Oct 07
15:10 UTC
|
BNTX
BioNTech
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Overweight | $115.00→ $114.00-0.9% |
|
Oct 07
15:10 UTC
|
AMGN
Amgen
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Equal Weight | $362.00→ $359.00-0.8% |
|
Oct 07
15:10 UTC
|
ABBV
AbbVie
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Overweight | $296.00→ $310.00+4.7% |
|
Oct 07
15:10 UTC
|
AA
Alcoa
|
◎ Target | Carlos De Alba ★★★☆☆ #2201 | Equal Weight | $53.00→ $50.00-5.7% |
|
Oct 07
14:10 UTC
|
ZS
Zscaler
|
◎ Target | John DiFucci ★★★☆☆ #1055 | Buy | $214.00→ $254.00+18.7% |
|
Oct 07
14:10 UTC
|
ZS
Zscaler
|
◎ Target | Shaul Eyal ★★★☆☆ #1664 | Buy | $200.00→ $230.00+15.0% |
|
Oct 07
14:10 UTC
|
ZS
Zscaler
|
◎ Target | Adam Borg ★★★☆☆ #1011 | Buy | $200.00→ $235.00+17.5% |
|
Oct 07
14:10 UTC
|
TXG
10x Genomics
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $52.00→ $110.00+111.5% |
|
Oct 07
14:10 UTC
|
TSN
Tyson Foods
|
◎ Target | Michael Lavery ★★★☆☆ #1755 | Overweight | $66.00→ $56.00-15.2% |
|
Oct 07
14:10 UTC
|
PENG
Penguin Solutions
|
◎ Target | Brian Chin ★★★☆☆ #2245 | Buy | $75.00→ $85.00+13.3% |
|
Oct 07
14:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | David O'Connor ★★★★☆ #441 | Overweight | $270.00→ $400.00+48.1% |
|
Oct 07
14:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | Tore Svanberg ★★☆☆☆ #2413 | Buy | $350.00→ $370.00+5.7% |
|
Oct 07
14:10 UTC
|
LW
Lamb Weston
|
◎ Target | Marc Torrente ★★☆☆☆ #2538 | Overweight | $57.00→ $54.00-5.3% |
|
Oct 07
14:10 UTC
|
LOB
Live Oak Bancshares
|
◎ Target | Crispin Love ★★★☆☆ #1144 | Neutral | $46.00→ $38.00-17.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.